K252752 is an FDA 510(k) clearance for the ellacor System with Micro-Coring Technology. Classified as Powered Microneedle Device (product code QAI), Class II - Special Controls.
Submitted by Cytrellis Biosystems, Inc. (Woburn, US). The FDA issued a Cleared decision on October 30, 2025 after a review of 62 days - a notably fast clearance cycle.
This device falls under the General & Plastic Surgery FDA review panel, regulated under 21 CFR 878.4430 - the FDA general and plastic surgery device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.
Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.
View all Cytrellis Biosystems, Inc. devices